283 related articles for article (PubMed ID: 33276026)
1. Integrative molecular characterisation of gallbladder cancer reveals micro-environment-associated subtypes.
Nepal C; Zhu B; O'Rourke CJ; Bhatt DK; Lee D; Song L; Wang D; Van Dyke AL; Choo-Wosoba H; Liu Z; Hildesheim A; Goldstein AM; Dean M; LaFuente-Barquero J; Lawrence S; Mutreja K; Olanich ME; Lorenzo Bermejo J; ; Ferreccio C; Roa JC; Rashid A; Hsing AW; Gao YT; Chanock SJ; Araya JC; Andersen JB; Koshiol J
J Hepatol; 2021 May; 74(5):1132-1144. PubMed ID: 33276026
[TBL] [Abstract][Full Text] [Related]
2. Mutational spectrum and precision oncology for biliary tract carcinoma.
Lin J; Cao Y; Yang X; Li G; Shi Y; Wang D; Long J; Song Y; Mao J; Xie F; Bai Y; Zhang L; Yang X; Wan X; Wang A; Guan M; Zhao L; Hu K; Pan J; Huo L; Lu X; Mao Y; Sang X; Zhang H; Wang K; Wang X; Zhao H
Theranostics; 2021; 11(10):4585-4598. PubMed ID: 33754015
[No Abstract] [Full Text] [Related]
3. Whole-exome mutational landscape of neuroendocrine carcinomas of the gallbladder.
Liu F; Li Y; Ying D; Qiu S; He Y; Li M; Liu Y; Zhang Y; Zhu Q; Hu Y; Liu L; Li G; Pan W; Jin W; Mu J; Cao Y; Liu Y
Signal Transduct Target Ther; 2021 Feb; 6(1):55. PubMed ID: 33563892
[TBL] [Abstract][Full Text] [Related]
4. Establishment and characterization of 38 novel patient-derived primary cancer cell lines using multi-region sampling revealing intra-tumor heterogeneity of gallbladder carcinoma.
Feng F; Cheng Q; Li B; Liu C; Wang H; Li B; Xu X; Yu Y; Chen Z; Wu X; Dong H; Chu K; Xie Z; Gao Q; Xiong L; Li F; Yi B; Zhang D; Jiang X
Hum Cell; 2021 May; 34(3):918-931. PubMed ID: 33813726
[TBL] [Abstract][Full Text] [Related]
5. Association of Aflatoxin and Gallbladder Cancer.
Koshiol J; Gao YT; Dean M; Egner P; Nepal C; Jones K; Wang B; Rashid A; Luo W; Van Dyke AL; Ferreccio C; Malasky M; Shen MC; Zhu B; Andersen JB; Hildesheim A; Hsing AW; Groopman J
Gastroenterology; 2017 Aug; 153(2):488-494.e1. PubMed ID: 28428144
[TBL] [Abstract][Full Text] [Related]
6. Mutational landscape of paired primary and synchronous metastatic lymph node in chemotherapy naive gallbladder cancer.
Fan B; Xu X; Wang X
Mol Biol Rep; 2022 Feb; 49(2):1295-1301. PubMed ID: 34988893
[TBL] [Abstract][Full Text] [Related]
7. High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification.
Olbrecht S; Busschaert P; Qian J; Vanderstichele A; Loverix L; Van Gorp T; Van Nieuwenhuysen E; Han S; Van den Broeck A; Coosemans A; Van Rompuy AS; Lambrechts D; Vergote I
Genome Med; 2021 Jul; 13(1):111. PubMed ID: 34238352
[TBL] [Abstract][Full Text] [Related]
8. Loss of BAP1 expression is associated with genetic mutation and can predict outcomes in gallbladder cancer.
Hirosawa T; Ishida M; Ishii K; Kanehara K; Kudo K; Ohnuma S; Kamei T; Motoi F; Naitoh T; Selaru FM; Unno M
PLoS One; 2018; 13(11):e0206643. PubMed ID: 30395583
[TBL] [Abstract][Full Text] [Related]
9. RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancer.
Manzano RG; Catalan-Latorre A; Brugarolas A
BMC Cancer; 2021 Apr; 21(1):432. PubMed ID: 33879103
[TBL] [Abstract][Full Text] [Related]
10. Functional and genomic characterization of three novel cell lines derived from a metastatic gallbladder cancer tumor.
García P; Bizama C; Rosa L; Espinoza JA; Weber H; Cerda-Infante J; Sánchez M; Montecinos VP; Lorenzo-Bermejo J; Boekstegers F; Dávila-López M; Alfaro F; Leiva-Acevedo C; Parra Z; Romero D; Kato S; Leal P; Lagos M; Roa JC
Biol Res; 2020 Apr; 53(1):13. PubMed ID: 32293552
[TBL] [Abstract][Full Text] [Related]
11. Whole Exome and Transcriptome Analyses Integrated with Microenvironmental Immune Signatures of Lung Squamous Cell Carcinoma.
Seo JS; Lee JW; Kim A; Shin JY; Jung YJ; Lee SB; Kim YH; Park S; Lee HJ; Park IK; Kang CH; Yun JY; Kim J; Kim YT
Cancer Immunol Res; 2018 Jul; 6(7):848-859. PubMed ID: 29720381
[TBL] [Abstract][Full Text] [Related]
12. Expression and functional characterization of INPP4B in gallbladder cancer patients and gallbladder cancer cells.
Wu Y; Meng D; Xu X; Bao J; You Y; Sun Y; Li Y; Sun D
BMC Cancer; 2021 Apr; 21(1):433. PubMed ID: 33879096
[TBL] [Abstract][Full Text] [Related]
13. Stepwise correlation of TP53 mutations from pancreaticobiliary maljunction to gallbladder carcinoma: a retrospective study.
Kawakami S; Takano S; Fukasawa M; Shindo H; Takahashi E; Fukasawa Y; Hayakawa H; Kuratomi N; Kadokura M; Hosomura N; Amemiya H; Kawaida H; Kono H; Maekawa S; Ichikawa D; Enomoto N
BMC Cancer; 2021 Nov; 21(1):1245. PubMed ID: 34798839
[TBL] [Abstract][Full Text] [Related]
14. Genomic
Li M; Liu F; Zhang F; Zhou W; Jiang X; Yang Y; Qu K; Wang Y; Ma Q; Wang T; Bai L; Wang Z; Song X; Zhu Y; Yuan R; Gao Y; Liu Y; Jin Y; Li H; Xiang S; Ye Y; Zhang Y; Jiang L; Hu Y; Hao Y; Lu W; Chen S; Gu J; Zhou J; Gong W; Zhang Y; Wang X; Liu X; Liu C; Liu H; Liu Y; Liu Y
Gut; 2019 Jun; 68(6):1024-1033. PubMed ID: 29954840
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological features and CCT2 and PDIA2 expression in gallbladder squamous/adenosquamous carcinoma and gallbladder adenocarcinoma.
Zou Q; Yang ZL; Yuan Y; Li JH; Liang LF; Zeng GX; Chen SL
World J Surg Oncol; 2013 Jun; 11():143. PubMed ID: 23782473
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of vascular endothelial growth factor A in advanced gallbladder carcinoma.
Letelier P; Garcia P; Leal P; Ili C; Buchegger K; Riquelme I; Sandoval A; Tapia O; Roa JC
Appl Immunohistochem Mol Morphol; 2014 Aug; 22(7):530-6. PubMed ID: 24185122
[TBL] [Abstract][Full Text] [Related]
17. Serial analysis of gene expression identifies connective tissue growth factor expression as a prognostic biomarker in gallbladder cancer.
Alvarez H; Corvalan A; Roa JC; Argani P; Murillo F; Edwards J; Beaty R; Feldmann G; Hong SM; Mullendore M; Roa I; Ibañez L; Pimentel F; Diaz A; Riggins GJ; Maitra A
Clin Cancer Res; 2008 May; 14(9):2631-8. PubMed ID: 18451226
[TBL] [Abstract][Full Text] [Related]
18. RNA sequencing revealed the multi-stage transcriptome transformations during the development of gallbladder cancer associated with chronic inflammation.
Yang S; Qin L; Wu P; Liu Y; Zhang Y; Mao B; Yan Y; Yan S; Tan F; Yue X; Liu H; Xue H
PLoS One; 2023; 18(3):e0283770. PubMed ID: 36996251
[TBL] [Abstract][Full Text] [Related]
19. Single-cell RNA-sequencing atlas reveals an MDK-dependent immunosuppressive environment in ErbB pathway-mutated gallbladder cancer.
Zhang Y; Zuo C; Liu L; Hu Y; Yang B; Qiu S; Li Y; Cao D; Ju Z; Ge J; Wang Q; Wang T; Bai L; Yang Y; Li G; Shao Z; Gao Y; Li Y; Bian R; Miao H; Li L; Li X; Jiang C; Yan S; Wang Z; Wang Z; Cui X; Huang W; Xiang D; Wang C; Li Q; Wu X; Gong W; Liu Y; Shao R; Liu F; Li M; Chen L; Liu Y
J Hepatol; 2021 Nov; 75(5):1128-1141. PubMed ID: 34171432
[TBL] [Abstract][Full Text] [Related]
20. Circular RNA FOXP1 promotes tumor progression and Warburg effect in gallbladder cancer by regulating PKLR expression.
Wang S; Zhang Y; Cai Q; Ma M; Jin LY; Weng M; Zhou D; Tang Z; Wang JD; Quan Z
Mol Cancer; 2019 Oct; 18(1):145. PubMed ID: 31623628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
